Efficacy of 90Y ibritumomab-tiuxetan treatment in a case of resistant gastric MALT non-Hodgkin’s lymphoma

Treatment modalities for resistant/relapsing gastric mucosa associated lymphoid tissue (MALT) non-Hodgkin’s lymphoma (NHL) are not yet well standardized. In the past, most patients were treated surgically with a gastrectomy, while, more recently, radiotherapy and systemic approaches (chemotherapy an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrucci, PF, Vanazzi, A, Crosta, C, Pruneri, G, Grana, C, Bartolomei, M, Paganelli, G, Martinelli, G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2008
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234051/
https://www.ncbi.nlm.nih.gov/pubmed/22275968
http://dx.doi.org/10.3332/eCMS.2008.79

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3234051/
https://www.ncbi.nlm.nih.gov/pubmed/22275968
http://dx.doi.org/10.3332/eCMS.2008.79

Ejemplares similares